This Week in Rheumatology — Jun 17, 2026

AudioScholar Rheumatology Weekly · Jun 17, 2026 · 9m

Welcome to This Week in Rheumatology. This week we're covering 8 notable papers spanning advances in precision monitoring and biomarkers, new insights into long-term risk and disease pathogenesis, and a look at novel therapeutics in related fields. Let's dive in.

This week's papers:

Talquetamab-Daratumumab in Relapsed or Refractory Myeloma. — The New England journal of medicine 2026

Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease. — The New England journal of medicine 2026

Longitudinal profiling reveals immune dynamics and distinct plasma cell signatures during…